Clinical Trial Update: Efficacy of IgM Rich Immunoglobulin With Antibiotics for Bacterial Sepsis in Very Low Birth Weight Preterm Neonates [Phase 4]

View source ↗

Summary

Phase 4 trial assessing IgM-rich immunoglobulin with antibiotics for bacterial sepsis in very low birth weight preterm neonates has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis
• Very Low Birth Weight Infant Sepsis

Drugs mentioned

• IgM rich immunoglobulin (IgM-rich immunoglobulin)

Snippet

Sponsor: Sir Takhtasinhji General Hospital | Conditions: Neonatal SEPSIS, Very Low Birth Weight Baby | Phase 4 | Status: COMPLETED